EMA second-in-command retires after 25 years at the organization

On Thursday, the European Medicines Agency bids farewell to one of the agency's central figures.

Photo: Rob Acket/EMA

Since 1996, Belgian Noël Wathion has been employed by the EMA in various roles. He is now retiring from his role as Deputy Executive Director and Chief of Policy which he has held since 2016, according to the European Medicines Agency (EMA).

"Noël Wathion’s retirement brings to a close an exceptional career of service to public health in the EU and I would like to thank him, on behalf of the Agency, for his remarkable contribution to EMA’s work over the last 25 years."

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs